Medicine
Showing 701-750 of 1,188 Results
-
Thomas Charles Merigan M.D.
George E. and Lucy Becker Professor of Medicine, Emeritus
Current Research and Scholarly InterestsI am now emeritus and only participate in university activities through advising my former trainees who have joined the faculty.
-
Matthew Mesias
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioMatthew Mesias, M.D., is a Geriatrician and Clinical Associate Professor of Medicine at Stanford University School of Medicine. He completed his medical degree at Johns Hopkins University School of Medicine and furthered his training internal medicine residency and geriatrics fellowship at the University of Washington. He serves as the Medical Director of the Inpatient Geriatrics Consult Service at Stanford University Hospital. His academic interests include quality improvement in geriatric care, mentorship of medical trainees, and the development of curricula for geriatrics medical education. In 2023, he was awarded the HRSA Geriatric Academic Career Award, which supports his leadership and professional development while creating geriatric educational programs for community-partnered clinics.
-
Everett Meyer
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and of Pediatrics (Stem Cell Transplantation)
Current Research and Scholarly InterestsResearch focus in T cell immunotherapy and T cell immune monitoring using high-throughput sequencing and genomic approaches, with an emphasis on hematopoietic stem cell transplantation, the treatment of graft-versus-host disease and immune tolerance induction.
-
Timothy Meyer
Stanford University Professor of Nephrology, Emeritus
Current Research and Scholarly InterestsInadequate removal of uremic solutes contributes to widespread illness in the more than 500,000 Americans maintained on dialysis. But we know remarkably little about these solutes. Dr. Meyer's research efforts are focused on identifying which uremic solutes are toxic, how these solutes are made, and how their production could be decreased or their removal could be increased. We should be able to improve treatment if we knew more about what we are trying to remove.
-
Lekha Mikkilineni
Assistant Professor of Medicine (Blood and Marrow Transplantation & Cellular Therapy)
BioDr. Lekha Mikkilineni is a board-certified medical oncologist. She is also an Assistant Professor in the Department of Medicine, Division of Blood & Marrow Transplant and Cellular Therapy.
Dr. Mikkilineni has extensive experience treating blood and bone marrow cancers. She currently provides care through the Bone Marrow Transplant & Cellular Therapy Program at Stanford Health Care. Her clinical focus is multiple myeloma, plasma-cell leukemia, Extramedullary myeloma, high-risk myeloma, CAR T cell therapy, bispecific therapy, amyloidosis, POEMS syndrome, and Waldenstrom’s macroglobunemia.
Dr. Mikkilineni’s research centers on exploring novel CAR T-cell therapies to treat multiple myeloma and to define mechanisms of resistance to immunotherapy. She is particularly focused on understanding how to improve therapies for multiple myeloma patients who have extramedullary disease or high-risk features. Prior to coming to Stanford, she ran phase 1 CAR T-cell trials for multiple myeloma targeting BCMA and SLAMF7 at the National Cancer Institute.
Dr. Mikkilineni received the Conquer Cancer Foundation Young Investigator Award from the American Society of Clinical Oncology for her research focusing on SLAMF7 as a potential target for multiple myeloma. She has received honors and awards for her work at the NCI. She has completed fellowships in hematology/oncology and immunotherapy at the National Heart, Lung, and Blood Institute/National Cancer Institute. She finished her residency in internal medicine at Thomas Jefferson University Hospital. She holds a Master of Science in medical sciences from Boston University and a medical degree from Tulane University.
Dr. Mikkilineni has authored book chapters and published research in numerous high-impact academic journals. She has presented her findings through oral and poster presentations at national and international conferences. -
David Miklos
James and Katherine Lau Professor
Current Research and Scholarly InterestsDr. Miklos is the Chief of BMT & Cell Therapy Program. He leads clinical trials treating patients with lymphoma. His correlative research studies: 1) tumor antigen quantification, 2) single cell functional product characterization, 3) CAR-FACS immune phenotyping of blood and tumor, and identifying mechanisms for CAR-T treatment Failure including antigen loss, CAR-T exhaustion, and CAR suppression.
-
Carlos Milla
Professor of Pediatrics (Pulmonary Medicine) and, by courtesy, of Medicine (Pulmonary, Allergy and Critical Care Medicine)
Current Research and Scholarly InterestsAt Stanford University I developed and currently direct the CF Translational Research Center. The overarching goal of the center is to provide the groundwork to streamline, accelerate, and promote the translation of basic discoveries into effective therapies and interventions to benefit patients affected by cystic fibrosis. My laboratory group currently has three main lines of investigation: respiratory cell biology in CF; remote biochemical monitoring; and lung physiology in young children.
-
Arnold Milstein
Professor of Medicine (General Medical Discipline)
Current Research and Scholarly InterestsDesign national demonstration of innovations in care delivery that provide more with less. Informed by research on AI-assisted clinical workflow, positive value outlier analysis and triggers of loss aversion bias among patients and clinicians.
Research on creation of a national index of health system productivity gain. -
Vijay Mirmira
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Mirmira believes that excellent communication leads to excellent care, and is dedicated to the health and well-being of his patients and their families. He is fluent in English, Hindi, Tamil and Kannada and has working knowledge of Urdu and Telugu. Apart from enjoying practicing the full scope of family medicine, Dr. Mirmira's special interests include diabetes and thyroid disorders, and pediatric illnesses. He likes to travel and read fiction in his free time.
-
Alicia Mirza
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Alicia Mirza is quadruple board-certified in Internal Medicine, Pediatrics, Pulmonary Medicine, and Critical Care Medicine. She is now an Assistant Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine (PACCM) at Stanford, where she serves as Associate Director of the Adult Cystic Fibrosis (CF) Program.
She has expertise across a breadth of pulmonary and intensive care domains, with her clinical and research interests centering on CF and bronchiectasis. She is a CF Foundation (CFF) Program for Adult Care Excellence grant awardee. She has worked on quality improvement projects in adult CF care, including initiatives in advanced care planning, pediatric to adult transitions, primary care utilization, and remote monitoring. She is involved in clinical trials as well as registry-based research in both CF and non-CF bronchiectasis.
Nationally, Dr. Mirza was elected to the CHEST Bronchiectasis Network, where she collaborates with experts across the country to expand education in bronchiectasis through podcasts, training modules, and lectures. An active educator, Dr. Mirza teaches Stanford medical students, residents, and fellows. She is engaged both locally and internationally through conference presentations at CHEST, California Thoracic Society, and the North American CF Conference.
She also serves as Co-director of Wellbeing for Stanford PACCM, where she is committed to advancing faculty wellness and fostering a culture of professional fulfillment. In both her clinical and academic work, she emphasizes a holistic approach to supporting patients and colleagues alike, with attention to the whole person and the systems that sustain their health and wellbeing. -
Beverly S. Mitchell, M.D.
George E. Becker Professor of Medicine, Emerita
Current Research and Scholarly InterestsBeverly Mitchell's research relates to the development of new therapies for hematologic malignancies, including leukemias and myelodsyplastic syndromes. She is interested in preclinical proof of principle studies on mechanisms inducing cell death and on metabolic targets involving nucleic acid biosynthesis in malignant cells. She is also interested in the translation of these studies into clinical trials.
-
Maha Abdalla Mohamed, MD, FACP, FAST
Clinical Associate Professor, Medicine - Nephrology
BioDr. Mohamed is a board-certified, fellowship-trained nephrologist with the Kidney and Pancreas Transplant Program at Stanford Healthcare. She is a clinical associate professor in the Department of Medicine, Division of Nephrology.
Dr. Mohamed specializes in kidney and pancreas transplant outcomes and kidney transplant health equity. Conditions she treats include allografts rejection, recipient BK virus and CMV infection, and post-transplant lymphoproliferative disorder management. Dr. Mohamed is known for her personalized and comprehensive approach to patient care. She takes the time to understand her patients’ unique health needs and creates tailored care plans that fit their lifestyles.
Dr. Mohamed’s research interests include examining new approaches to improving kidney transplant long-term outcome including kidney transplant rejection and infection. She also seeks to develop better screening and monitoring guidance to help reduce post-transplant BK virus and CMV infection.
Dr. Mohamed’s published work can be found in peer-reviewed journals such as Clinical Transplantation, Transplant Infectious Disease and Transplantation. She has presented to her peers at international, national, and regional meetings, including at the American Transplant Congress and the American Society of Nephrology. She has also been invited to speak multiple times at King Faisal Hospital in Rwanda as well as in Kingdom of Saudi Arabia on topics like post-transplant lymphoproliferative disorder, update in kidney transplant rejection, and update in living-donor kidney transplantation.
Dr. Mohamed is a faculty fellow of Stanford Center for Innovation in Global Health, fellow of the American Society of Transplantation, a board of managers member of the AST Transplant Nephrology Fellowship Training Accreditation Program, member of the International Society of Nephrology and the American Society of Nephrology. -
Minal Moharir
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioI was born, raised, and trained in Nashik, India where I completed my formal Medical Education before moving to New York City where I completed my residency in Internal Medicine at New York Downtown Hospital in New York, NY. My interests are in preventative medicne, health and wellness, occupational and environmental safety. In Stanford's Occupational Health Department, I practice clinical occupational medicine while working toward identifying health and safety issues within our enviroment to prevent further injury and illness to our employees.
-
Tamara Montacute, MD, MPH
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioTamara Kailoa Montacute is a board certified Family Medicine physician. She enjoys taking care of the entire family (including kids), and has special interest in women’s health, adolescent health, community health, chronic disease management, mental health and office based procedures. She also speaks Spanish.
She was born in New Zealand, grew up in England and moved to Seattle when she was twelve. Prior to attending medical school at Stanford, she completed her Masters in Public Health at Columbia University and spent several years working on public health programs in Mexico, Panama, Ethiopia and Rwanda. After medical school, she completed a Family Medicine Residency at O’Connor Hospital in San Jose. She is the co-medical director of Arbor Free Clinic, teaches several primary care focused medical student courses and spends part of her time caring for patients at the Samaritan House Free Clinics in Redwood City and San Mateo.
Outside the clinic, she enjoys hiking, biking, gardening and playing with her daughter and 2 dogs. -
Maria Emilia Montez Rath
Assistant Professor (Research) of Medicine (Nephrology)
BioDr. Montez-Rath completed her PhD in Biostatistics from Boston University in 2008 focusing on methods for modeling interaction effects in studies involving populations with high levels of comorbidity, such as persons on dialysis. She is a senior biostatistician and director of the Biostatistics Core of the Division of Nephrology at Stanford University where she has been collaborating with faculty and fellows since 2010 to study a variety of research questions relevant to kidney disease. Her methodological interests are mainly data-driven and include the handling of missing data, survival analysis with an emphasis on models for time-varying covariates and competing risks, methods for analyzing epidemiologic studies, analysis of correlated data and comparative effectiveness studies, as well as data visualization.
-
Joshua Mooney
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsOutcomes and Health Services Research in Advanced Lung Disease & Lung Transplant
-
Andrew Reese Moore
Instructor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsI am co-mentored by Dr. Angela Rogers and Dr. Purvesh Khatri. My research focuses on leveraging machine learning on multi-omic data to evaluate the immune response in critical illness. It is striking that despite many years of studying infections, we still treat patients with severe infections the same as we did 30 years ago, with antimicrobials, fluids, and supportive care. The goal of my research is to bring the ideals of precision medicine to critical care. In particular, I am working to better quantify how the immune system responds to infections with the goal of being able to "read" the immune system and treat patients with the medications they need to successfully recover.
-
Nancy Morioka-Douglas, MD, MPH
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly Interests--Community outreach to underserved populations to address health care disparities, chronic illness prevention, and health promotion.
--Chronic illness care: implementing optimal care for these patients and training the next generation of physicians in these best practices.
--Enhancing physician and staff satisfaction in caring for patients -
Meagan Moyer
Academic Staff - Hourly - CSL, Medicine - Primary Care and Population Health
BioI am a lecturer in the School of Medicine's Clinical Informatics Management master of science program. I co-instruct the autumn through spring quarters practicum courses. Students in my courses gain a foundational knowledge of health policy, learn from experts in the field of health technology, and complete a capstone project that brings together learnings from the entire program into a meaningful deliverable that furthers their career and the field of clinical informatics and digital health technology.
-
Alisa Mueller, MD, PhD
Assistant Professor of Medicine (Immunology and Rheumatology)
BioDr. Mueller is an Assistant Professor in the Division of Immunology and Rheumatology. As a physician-scientist, she leads a research laboratory investigating mechanisms that drive stromal pathology in rheumatoid arthritis and other chronic inflammatory conditions. Utilizing innovative techniques in immunology, genomics, and regenerative medicine, she and her team aim to develop novel therapeutic approaches to combat autoimmune diseases.
Dr. Mueller earned her MD and PhD degrees at Stanford University as part of the Medical Scientist Training Program where she investigated mechanisms regulating a mesenchymal progenitor population in skeletal muscle that mediates both healthy tissue regeneration and pathologic fibrosis. During her training, she was awarded predoctoral grants from the NIH National Institute on Aging and the California Institute of Regenerative Medicine. Her studies culminated in a first-author publication in Nature and co-authorship on publications in Cell and Nature Communications. Subsequently, she pursued medicine residency and rheumatology fellowship at Brigham and Women’s Hospital and Harvard Medical School where she explored mechanisms driving synovial fibroblast pathogenicity in rheumatoid arthritis. Her work led to the identification of non-canonical Wnt signaling as a critical mediator of RA synovial fibroblast inflammatory activation as well as the development of functional genomic screens to elucidate a broad set of novel therapeutic targets in inflammatory fibroblasts. Moreover, she has also led high-dimensional immunoprofiling studies to reveal underlying immune aberrations in patients with systemic sclerosis and elucidate biologic mechanisms catalyzing disease in patients with longstanding immune-related disorders of unknown etiology in partnership with the Undiagnosed Diseases Network. During her fellowship and instructorship, she received a Distinguished Fellow Award from the American College of Rheumatology as well as grants including the NIH NIAMS Mentored Clinical Scientist Research Career Development Award (K08), Rheumatology Research Foundation Scientist Development Award with the Malawista Endowment Distinction, Hearst Young Investigator Award, and Innovation Evergreen Fund Award. Her work has resulted in co-first author publications in the Journal of Clinical Investigation, Cell Reports Medicine, and ACR Open Rheumatology as well as as co-authorship on publications in Lancet Rheumatology and the New England Journal of Medicine.
In addition to her scientific endeavors, Dr. Mueller is also dedicated to providing high quality clinical care and education. She serves as an attending physician specializing in rheumatology where she mentors trainees in outpatient and inpatient settings and provides educational lectures. With an interdisciplinary team, she developed an interactive medical case on neurologic manifestations of lupus which was published in the New England Journal of Medicine. She was awarded an Arnold Dunne Award for Compassion and Dedication to Patient Care at Brigham and Women’s Hospital. By pursuing basic and translational research alongside clinical care, Dr. Mueller and her team strive to uncover basic mechanisms regulating stromal biology in autoimmune and inflammatory disease development and to create diagnostic strategies and targeted therapeutics that will benefit patients who do not respond to conventional therapies. -
Lori Muffly
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsDr. Muffly's interests include investigator initiated clinical trials focused on cellular therapies for adults with acute lymphoblastic leukemia and acute myeloid leukemia. She also has an active health outcomes research program focused on patterns of care and improving access to care for adults with acute leukemia.
-
Ann Mullally
George E. Becker Professor in Medicine
Current Research and Scholarly InterestsDr. Ann Mullally's aboratory studies the genetics, biology and therapy of myeloid blood cancers, with a focus on myeloproliferative neoplasms (MPN). Using primary human samples, mouse models, genomics, single-cell sequencing and CRISPR, as well as cellular and molecular biology, the lab has investigated the key genetic events underlying MPN pathogenesis. Dr. Mullally’s lab elucidated the mechanism by which mutant calreticulin (CALR) is oncogenic and causes MPN.
-
Mark Musen
Stanford Medicine Professor of Computational Medicine, Professor of Medicine (Computational Medicine) and of Biomedical Data Science
Current Research and Scholarly InterestsModern science requires that experimental data—and descriptions of the methods used to generate and analyze the data—are available online. Our laboratory studies methods for creating comprehensive, machine-actionable descriptions both of data and of experiments that can be processed by other scientists and by computers. We are also working to "clean up" legacy data and metadata to improve adherence to standards and to facilitate open science broadly.
-
Sanjiv Narayan
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Narayan directs the Computational Arrhythmia Research Laboratory, whose goal is to define the mechanisms underlying complex human heart rhythm disorders, to develop bioengineering-focused solutions to improve therapy that will be tested in clinical trials. The laboratory has been funded continuously since 2001 by the National Institutes of Health, AHA and ACC, and interlinks a disease-focused group of clinicians, computational physicists, bioengineers and trialists.
-
Neha Narula
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Neha Narula is a Family Physician and Clinical Assistant Professor at Stanford University School of Medicine. She provides comprehensive primary care to a diverse patient population while also teaching medical students and residents. Beyond her clinical work, Dr. Narula serves as a medical correspondent for CBS News and has contributed to publications including The Wall Street Journal, Yahoo News, and USA Today. Her professional interests include Women’s health, Neurology in primary care, Obesity medicine, Integrative and Lifestyle Medicine, as well as Health Equity and Medical Humanities.
-
Ashwin K Nayak
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsConversational AI, Large Language Models, Digital Therapeutics
-
Joel Neal, MD, PhD
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsI am a thoracic oncologist who cares for patients with non-small cell lung cancer, malignant mesothelioma, and other thoracic malignancies. I design and conduct clinical trials of novel therapies in collaboration with other researchers and pharmaceutical companies. These generally focus on two areas, 1) targeted therapies against particular mutations in cancers (for example EGFR, ALK, ROS1, HER2, KRAS, MET, and others) and 2) the emerging field of immunotherapy in cancer, using anti PD-1/PD-L1 therapies in combination with other agents, and also developing cellular therapies. I also collaborate with other researchers on campus to apply emerging technologies to cancer therapy, for example, circulating tumor DNA detection. Additionally, in my role as the Cancer Center IT Medical Director, I coordinate projects relating to our use of the electronic health record to improve provider efficiency and facilitate patient care.
-
Robert Negrin
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsOur labaratory focuses on the study of immune recognition by T and NK cells with special emphasis on graft vs host disease and graft vs tumor reactions. We utilize both murine and human systems in an effort to enhance graft vs tumor reactions while controlling graft vs host disease. We have developed bioluminescence models in collaboration with the Contag laboratory to study the trafficking of immune effector cells with a special emphasis on NK, T and regulatory T cells.
-
Joanna Nelson
Clinical Associate Professor, Medicine - Infectious Diseases
BioDr. Nelson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have had solid organ or bone marrow transplantation or who have malignancy undergoing chemotherapy. She also has a special interest in caring for patients with Cystic fibrosis or who have had a lung transplant as well as Nontuberculous mycobacterial Infections.
